BackAstraZeneca PLC Overview

AstraZeneca PLC Other Current Liabilities

Track AstraZeneca PLC's other current liabilities ($770M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$767.00M
48.87% YoYΔ $-733.00M vs prior year quarter

Peer trimmed avg / median

Loading

AstraZeneca PLC Other Current Liabilities History

Loading

AstraZeneca PLC vs. peers: Other Current Liabilities Comparison

Loading

AstraZeneca PLC Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AstraZeneca PLC (AZNCF) FAQ

AstraZeneca PLC (AZNCF) currently reports a other current liabilities of $770M as of December 2025. That compares with $1.5B in the prior-year period — down 48.9% year over year. Use the charts on this page to explore AstraZeneca PLC's other current liabilities history and peer comparisons.

AstraZeneca PLC's other current liabilities decreased from $1.5B to $770M — a 48.9% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AstraZeneca PLC reported $770M in other current liabilities as of December 2025. That compares with $1.5B in the prior-year period — down 48.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $770M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AstraZeneca PLC, and consider following AZNCF for alerts when major investors trade the stock.

AstraZeneca PLC is classified in the Healthcare sector. On other current liabilities, it currently shows $770M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AZNCF with unrelated industries.